My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Unity Biotechnology, Inc. - Common Stock (NQ:UBX)

0.2001 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Unity Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023 ↗

April 15, 2024

UBX stock results show that Unity Biotechnology beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 19, 2024

Via Benzinga

Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution ↗

November 16, 2023

Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and

Via Benzinga

Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks ↗

October 17, 2023

Here are the best longevity stocks to consider. Each stock listed comes with their unique reasons to buy them.

Via InvestorPlace

Analyst Ratings for Unity Biotechnology ↗

August 09, 2023

Via Benzinga

The Latest Analyst Ratings for Unity Biotechnology ↗

June 26, 2023

Via Benzinga

Where Unity Biotechnology Stands With Analysts ↗

May 26, 2023

Via Benzinga

Recap: Unity Biotechnology Q1 Earnings ↗

May 09, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023 ↗

June 26, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023 ↗

May 31, 2023

Via Benzinga

Where Unity Biotechnology Stands With Analysts ↗

April 25, 2023

Via Benzinga

Expert Ratings for Unity Biotechnology ↗

March 28, 2023

Via Benzinga

Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea ↗

April 24, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 29, 2023

On Wednesday, 81 companies hit new 52-week lows.

Via Benzinga

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 28, 2023

During Tuesday, 95 stocks hit new 52-week lows.

Via Benzinga

Nasdaq Edges Lower; Unity Biotechnology Shares Plummet ↗

March 27, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while the NASDAQ fell 0.09% to 11,813.90. The S&P 500, also...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 27, 2023

Via Benzinga

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 27, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 27, 2023

On Monday, 89 stocks made new 52-week lows.

Via Benzinga

Why Is Codiak BioSciences (CDAK) Stock Down 52% Today? ↗

March 27, 2023

Codiak BioSciences (CDAK) stock is falling hard on Monday after the company announced plans for an asset sale via a Chapter 11 bankruptcy.

Via InvestorPlace

Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher ↗

March 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 32,372.55 while the NASDAQ rose 0.01% to 11,825.46. The S&P 500, also...

Via Benzinga

Why Is Unity Biotechnology (UBX) Stock Down 52% Today? ↗

March 27, 2023

Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325.

Via InvestorPlace

UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug ↗

March 27, 2023

UNITY Biotechnology Inc (NASDAQ: UBX) announced results from Part A of the Phase 2 ENVISION study of UBX1325 in patients with wet age-related macular degeneration (AMD) who were not achieving optimum...

Via Benzinga

US Stocks Open Higher; Dow Rises 200 Points ↗

March 27, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 02, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.